NORMAN J CLEMENT RPH., DDS, NORMAN L.CLEMENT PHARM-TECH, MALACHI F. MACKANDAL PHARMD, BELINDA BROWN-PARKER, IN THE SPIRIT OF JOSEPH SOLVO ESQ., INC.T. SPIRIT OF REV. C.T. VIVIAN, JELANI ZIMBABWE CLEMENT, BS., MBA., IN THE SPIRIT OF THE HON. PATRICE LUMUMBA, IN THE SPIRIT OF ERLIN CLEMENT SR., WALTER F. WRENN III., MD., JULIE KILLINGWORTH, LESLY POMPY MD., NANCY SEEFELDT, WILLIE GUINYARD BS., JOSEPH WEBSTER MD., MBA, BEVERLY C. PRINCE MD., FACS., NEIL ANAND, MD., RICHARD KAUL, MD., LEROY BAYLOR, JAY K. JOSHI MD., MBA, ADRIENNE EDMUNDSON, ESTER HYATT PH.D., WALTER L. SMITH BS., IN THE SPIRIT OF BRAHM FISHER ESQ., MICHELE ALEXANDER MD., CUDJOE WILDING BS, MARTIN NJOKU, BS., RPH., IN THE SPIRIT OF DEBRA LYNN SHEPHERD, BERES E. MUSCHETT, STRATEGIC ADVISORS
AMERICA’S MOST DANGEROUS PSYCHIATRIST
The mishandling of pain care in America issued by CDC in 2016 is the directed result of an unqualified self-appointed Psychiatrist, Andrew Kolodny MD of Brandeis University.
Dr. Andrew Kolodny’s opinions continue to shape US Federal policies (CDC-DOJ-DEA) on pain care despite the fact he has “NO” subject matter expertise.
According to Josh Bloom Ph.D.:
Andrew Kolodny, MD Says:
“Chronic Pain Patients Are PR Pawns for Big Pharma“
“For the uninitiated, Andrew Kolodny is a self-appointed opioid regulator. His organization, Physicians for Responsible Opioid Prescribing (PROP), was largely responsible for a disastrous policy implemented by the CDC which ultimately made doctors afraid of prescribing opioids to chronic pain patients who needed them.”
HEALTHCARE FRAUD: HOW DOJ-DEA SO-CALLED EXPERT WAS PAID HUGE AMOUNTS FOR FRAUDULENT TESTIMONY ON PAIN CARE
Yet, he purports to be an expert and publicizes his rates of $725 an hour and earned $500,000 in just the State of Oklahoma vs. Johnson & Johnson trial in July 2019. Dr. Kolodny, a psychiatrist whose background is in public health and addictions medicine which does not qualify him to be a subject matter expert on narcotic analgesic (opioid) treatment of pain.
Josh Bloom writes:
“Worse, despite the restriction on opioid prescriptions, opioid overdose deaths continued to increase. Why?
Because the opioid crisis isn’t due to chronic pain patients becoming addicted to prescription pills. The actual problem, the history of which we detailed previously, is recreational drug users.
It is true that too many prescription opioids once flooded the market.
But they fell into the wrong hands — namely, recreational drug users — who have now switched to (often fentanyl-laced) heroin.
That’s the problem, and the data unambiguously prove it.
We aren’t the only organization to say this. In 2016, Scientific American wrote:
“According to the large, annually repeated and representative National Survey on Drug Use and Health, 75 percent of all opioid misuse start with people using medication that wasn’t prescribed for them—obtained from a friend, family member or dealer.”
NEW YORK TIMES
Andrew KolodNY, MD:
“Racial Biases’ Protected African-AMERICANS“
A ‘Rare Case Where Racial Biases’ Protected African-Americans???
One of the most disturbing and troubling examples of research bias appeared on December 5, 2019, New York Times on ” A Rare Case Where Racial Biases,’ Protected African-Americans.
- Published Nov. 25, 2019
Updated Dec. 2, 2019
Fewer opioid prescriptions meant fewer deaths (possibly 14,000), but the episode also reveals how prevalent and harmful stereotypes can be, even if implicit.
Starting in the 1990s, new prescription opioids were marketed more aggressively in white rural areas, where pain drug prescriptions were already high. African-Americans received fewer opioid prescriptions, some researchers think, because doctors believed, contrary to fact, that black people 1) were more likely to become addicted to the drugs 2) would be more likely to sell the drugs, and 3) had a higher pain threshold than white people because they were biologically different.
A fourth possibility is that some white doctors were more empathetic to the pain of people who were like them and less empathetic to those who weren’t. Some of this bias “can be unconscious,” said Dr. Andrew Kolodny, a director of opioid policy research at Brandeis University.
This accidental benefit for African-Americans is far outweighed by the long history of harm they have endured from inferior health care, including infamous episodes like the Tuskegee study.
And it doesn’t remedy the way damaging stereotypes continue to influence aspects of medical practice today.
“The reason to study this further is twofold,” Dr. Kolodny said. “It’s easy to imagine the harm that could come to blacks in the future, and we need to know what went wrong with whites, and how they were left exposed” to overprescribing. (see full article)
CONGRESS MUST CLEAN UP THIS MESS
FOR, NOW YOU ARE WITHIN